Target intelligence / Profile preview

Airway epithelial secretory machinery

Molecular classification
Protein complex, SNARE complex, Vesicle-trafficking proteins, GTP-binding proteins
01

Overview

The airway epithelial secretory machinery is a coordinated system of proteins and organelles responsible for the regulated exocytosis of mucins and other protective factors from specialized cells, such as goblet cells and submucosal gland cells. This machinery relies on a core set of proteins including the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex—specifically Syntaxin-3, SNAP-23, and VAMP-8—alongside regulatory proteins like Munc13-2, Munc18, and Synaptotagmin-2 (Davis & Dickey, 2008, Annual Review of Physiology). These components facilitate the docking, priming, and fusion of large mucin-containing granules with the apical plasma membrane in response to agonists like ATP or inflammatory mediators (Fahy & Dickey, 2010, NEJM). In chronic airway diseases such as asthma and COPD, the machinery is often upregulated or hyper-responsive, leading to pathological mucus hypersecretion and airway obstruction. Therapeutic targeting of this system, such as through the inhibition of the MARCKS protein which tethers granules to the cytoskeleton, aims to reduce excessive mucus release without completely abolishing the baseline secretion necessary for lung defense (Kim et al., 2015, American Journal of Respiratory Cell and Molecular Biology).

Other names
Mucus secretory apparatusAirway secretory pathwayExocytotic machinery of airway goblet cellsMucin secretory complex
02

Mechanism of action

Inhibition of vesicle docking and fusion, cleavage of SNARE proteins (e.g., SNAP-23), inhibition of MARCKS-mediated granule translocation, and disruption of Munc13-2-dependent priming of secretory granules.

03

Biological functions

ExocytosisMucus secretionProtein traffickingAirway clearanceInnate immunity
04

Disease associations

AsthmaChronic obstructive pulmonary disease (COPD)Cystic fibrosisChronic bronchitisBronchiectasis
05

Safety considerations

Impaired mucociliary clearanceIncreased risk of respiratory infectionPotential off-target effects on non-airway secretory cellsMucus impaction if fluid transport is not balanced
06

Interacting drugs

Botulinum toxin type A

3 more in the full profile.

07

Biomarkers

MUC5AC protein levelsMUC5B protein levelsSputum volumeMucus plug score (via CT imaging)Goblet cell hyperplasia

Beyond the preview

Go deeper on Airway epithelial secretory machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Airway epithelial secretory machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call